Nasdaq · Healthcare
INTUITIVE SURGICAL INC (ISRG)
As-reported financials and recent SEC filings for INTUITIVE SURGICAL INC, latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$10.06B
Net income
$2.86B
Net margin
28.4%
Diluted EPS
$7.87
ROE
15.9%
P/E (TTM)
50.0×
Market cap
$145.58B
Debt / equity
—
Income statement (as reported)
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $10.06B | $8.35B | $7.12B | $6.22B | $5.71B |
| Gross profit | $6.64B | $5.63B | $4.73B | $4.20B | $3.96B |
| Operating income | $2.95B | $2.35B | $1.77B | $1.58B | $1.82B |
| Net income | $2.86B | $2.32B | $1.80B | $1.32B | $1.70B |
| Diluted EPS | $7.87 | $6.42 | $5.03 | $3.65 | $4.66 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
1442026-06-08
View on EDGAR →1442026-06-03
View on EDGAR →42026-06-02
View on EDGAR →1442026-06-01
View on EDGAR →8-K2026-05-28
View on EDGAR →42026-05-22
View on EDGAR →SD2026-05-21
View on EDGAR →42026-05-20
View on EDGAR →Go deeper on ISRG
Search INTUITIVE SURGICAL INC’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeData sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.